Companies

Bryah Resources

Bryah Resources Limited (ASX:BYH) is a Western Australian gold-copper & manganese exploration company with its projects located in the Bryah Basin and Gabanintha in the Meekatharra region. Read more at www.bryah.com.au

Careteq Limited

CARETEQ (ASX:CTQ) is an Australian company with a focus on delivering best in class technology solutions for Health and Aged Care for a global audience. Read more at careteq.com.au

European Lithium

A mining exploration and development company focusing on its wholly owned Wolfsberg Lithium Project in Austria.  

FBR Limited

FBR designs, develops, builds and operates dynamically stabilised robots to address global needs. Read more at fbr.com.au

Fiji Kava

A medicinal Noble Kava company based in Australia that provides a natural solution to calm and soothe nerves, support muscle relaxation, increase mind relaxation and induce sleep.  

Foresta Limited

Foresta (NZ) Limited (ASX:FGH) manufactures pine wood pellets and pine chemicals from pine trees taken from sustainable surrounding forests.

GTI Energy

GTI Energy is focussed on exploring for, defining and developing economic Insitu Recovery (ISR) Uranium resources – GTI Energy is part of Wyoming’s ISR uranium mining renaissance. Read more at gtienergy.au

International Graphite

International Graphite (ASX:IG6) is building Australia’s capability in critical battery minerals and establishing a new ethical supply of battery anode graphite to support the global revolution in clean energy. Read more at internationalgraphite.technology

Island Pharmaceuticals

Island Pharmaceuticals is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. We have a lead asset – ISLA-101 - that was initially developed by our wholly owned subsidiary, Isla Pharmaceuticals. ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. Dengue fever is the very definition of an unmet medical need. While 390 million humans are infected each year, it is thought that around 30-50% people with the disease do not present with symptoms, enabling the virus to spread within communities. Warming global climates are accelerating the presence of mosquito-borne viruses that can cause death to the US, Europe and Australia There is no specific pharmaceutical treatment and the one vaccine which exists is available to a highly restricted audience. Island has repurposed ISLA-101, an antiviral oral drug to treat mosquito-borne viruses (eg dengue fever / Zika) and is planning to move forward with Phase II studies with a significantly de-risked clinical program.

Island Pharmaceuticals

Island Pharmaceuticals is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections Dengue fever is the very definition of an unmet medical need. While 390 million humans are infected each year, it is thought that around 30-50% people with the disease do not present with symptoms, enabling the virus to spread within communities. Warming global climates are accelerating the presence of mosquito-borne viruses that can cause death to the US, Europe and Australia Read more at www.islandpharmaceuticals.com

Lithium Plus Minerals

Lithium Universe

Lithium Universe (ASX: LU7) has a bold vision of building a Lithium resource and refinery facility in Canada that will provide the critical materials for batteries, helping the world transition towards cleaner energy. Lithium Universe is aiming to establish the Québec Lithium Processing Hub (QLPH). The QLPH is a major vertically integrated mine to battery grade lithium carbonate processing hub designed to feed the growing demand for lithium carbonate in the North American and European Battery Markets.